JP2008509113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509113A5 JP2008509113A5 JP2007524371A JP2007524371A JP2008509113A5 JP 2008509113 A5 JP2008509113 A5 JP 2008509113A5 JP 2007524371 A JP2007524371 A JP 2007524371A JP 2007524371 A JP2007524371 A JP 2007524371A JP 2008509113 A5 JP2008509113 A5 JP 2008509113A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- formula
- general formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000012453 solvate Substances 0.000 claims description 10
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 239000002253 acid Substances 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- -1 or C 1 -C 6 alkyl Chemical compound 0.000 claims 4
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 2
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical group C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000007514 Herpes zoster Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 102000003566 TRPV1 Human genes 0.000 claims 1
- 101150016206 Trpv1 gene Proteins 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 claims 1
- 208000014001 urinary system disease Diseases 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408652A FR2874015B1 (fr) | 2004-08-05 | 2004-08-05 | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR0408652 | 2004-08-05 | ||
| PCT/FR2005/002014 WO2006024776A1 (fr) | 2004-08-05 | 2005-08-02 | Derives de n-(1 h-indolyl)-i h-ind0le-2-carb0xamides, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008509113A JP2008509113A (ja) | 2008-03-27 |
| JP2008509113A5 true JP2008509113A5 (OSRAM) | 2008-09-18 |
| JP5100381B2 JP5100381B2 (ja) | 2012-12-19 |
Family
ID=34950701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007524371A Expired - Fee Related JP5100381B2 (ja) | 2004-08-05 | 2005-08-02 | Ｎ‐（１ｈ‐インドリル）‐１ｈ‐インドール‐２‐カルボキサミド誘導体、それらの調製法およびそれらの治療学的使用 |
Country Status (37)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2880625B1 (fr) | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
| FR2910473B1 (fr) * | 2006-12-26 | 2009-02-13 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique. |
| FR2911604B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| NZ582056A (en) * | 2007-08-10 | 2012-08-31 | Lundbeck & Co As H | Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation |
| WO2009078999A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| FR2926555B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
| FR2926556B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
| FR2926554B1 (fr) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| FR3007850B1 (fr) | 2013-06-28 | 2015-07-17 | Probayes | Systeme de prediction de temperature |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
| DE69735710T2 (de) * | 1996-02-13 | 2007-03-29 | Abbott Laboratories, Abbott Park | Neue benzo-1,3-dioxolyl-und benzofuranyl substituierte pyrrolidinederivate als endothelin antagonisten |
| TR200000993T2 (tr) * | 1997-08-04 | 2000-12-21 | Abbott Laboratories | Endotelin antagonistleri. |
| EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
| MXPA04005427A (es) * | 2001-12-10 | 2005-04-19 | Amgen Inc | Ligandos de receptor vainilloide y su uso en tratamientos. |
| PL375552A1 (en) * | 2002-05-22 | 2005-11-28 | Amgen Inc. | Vanilloid receptor ligands and their medical applications |
| JP2006511562A (ja) * | 2002-12-20 | 2006-04-06 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系疾患の処置のための置換２，５−ジアミドインドール類の使用 |
| DE602004024375D1 (de) | 2003-02-14 | 2010-01-14 | Glaxo Group Ltd | Carboxamidderivate |
| US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
-
2004
- 2004-08-05 FR FR0408652A patent/FR2874015B1/fr not_active Expired - Lifetime
-
2005
- 2005-02-08 UA UAA200702276A patent/UA90483C2/uk unknown
- 2005-08-02 CN CN2005800296989A patent/CN101010297B/zh not_active Expired - Fee Related
- 2005-08-02 PT PT05793766T patent/PT1776340E/pt unknown
- 2005-08-02 KR KR1020077002714A patent/KR101215162B1/ko not_active Expired - Fee Related
- 2005-08-02 JP JP2007524371A patent/JP5100381B2/ja not_active Expired - Fee Related
- 2005-08-02 DE DE602005011450T patent/DE602005011450D1/de not_active Expired - Lifetime
- 2005-08-02 WO PCT/FR2005/002014 patent/WO2006024776A1/fr not_active Ceased
- 2005-08-02 RS RSP-2009/0089A patent/RS50853B/sr unknown
- 2005-08-02 ZA ZA200700999A patent/ZA200700999B/xx unknown
- 2005-08-02 AU AU2005279085A patent/AU2005279085B2/en not_active Ceased
- 2005-08-02 ME MEP-2009-366A patent/ME01663B/me unknown
- 2005-08-02 HR HR20090101T patent/HRP20090101T3/xx unknown
- 2005-08-02 EA EA200700400A patent/EA011714B1/ru not_active IP Right Cessation
- 2005-08-02 AT AT05793766T patent/ATE416160T1/de active
- 2005-08-02 NZ NZ552924A patent/NZ552924A/en not_active IP Right Cessation
- 2005-08-02 BR BRPI0513087-5A patent/BRPI0513087A/pt not_active Application Discontinuation
- 2005-08-02 SI SI200530600T patent/SI1776340T1/sl unknown
- 2005-08-02 MX MX2007001436A patent/MX2007001436A/es active IP Right Grant
- 2005-08-02 ES ES05793766T patent/ES2318542T3/es not_active Expired - Lifetime
- 2005-08-02 PL PL05793766T patent/PL1776340T3/pl unknown
- 2005-08-02 DK DK05793766T patent/DK1776340T3/da active
- 2005-08-02 UY UY29046A patent/UY29046A1/es not_active Application Discontinuation
- 2005-08-02 EP EP05793766A patent/EP1776340B1/fr not_active Expired - Lifetime
- 2005-08-02 CA CA2576727A patent/CA2576727C/fr not_active Expired - Lifetime
- 2005-08-03 PE PE2005000900A patent/PE20060557A1/es not_active Application Discontinuation
- 2005-08-03 MY MYPI20053619A patent/MY139286A/en unknown
- 2005-08-04 AR ARP050103236A patent/AR050283A1/es not_active Application Discontinuation
- 2005-08-04 TW TW094126541A patent/TWI360538B/zh not_active IP Right Cessation
-
2007
- 2007-01-18 US US11/624,406 patent/US7384969B2/en not_active Expired - Fee Related
- 2007-01-23 IL IL180911A patent/IL180911A/en not_active IP Right Cessation
- 2007-01-29 EC EC2007007215A patent/ECSP077215A/es unknown
- 2007-02-01 CR CR8889A patent/CR8889A/es unknown
- 2007-02-05 TN TNP2007000041A patent/TNSN07041A1/fr unknown
- 2007-03-02 NO NO20071198A patent/NO340060B1/no not_active IP Right Cessation
- 2007-03-02 MA MA29730A patent/MA28845B1/fr unknown
-
2008
- 2008-04-25 US US12/109,388 patent/US7582671B2/en not_active Expired - Fee Related
-
2009
- 2009-02-19 CY CY20091100191T patent/CY1108816T1/el unknown
- 2009-07-21 US US12/506,322 patent/US7781477B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1071329C (zh) | 新颖的芳基甘氨酰胺衍生物,其制造方法及含该化合物的药物组合物 | |
| CA2546101C (en) | N-acylsulfonamide apoptosis promoters | |
| JP2983296B2 (ja) | 新規なｎ−アミノアルキルフルオレンカルボキサミド；新規な種類のドーパミンリセプタ亜型特異性リガンド | |
| JP2008509113A5 (OSRAM) | ||
| JP2015505301A5 (OSRAM) | ||
| WO2002030891A1 (en) | Aliphatic nitrogenous five-membered ring compounds | |
| JP2008520742A5 (OSRAM) | ||
| JP2002504484A (ja) | 新規化合物 | |
| JPS584752A (ja) | カルボキシアミド誘導体及びその製造法 | |
| JP2005519932A5 (OSRAM) | ||
| CN1202105A (zh) | 2－烷基吡咯烷化合物 | |
| JP2005505618A5 (OSRAM) | ||
| KR101796601B1 (ko) | 선택적 히스톤 탈아세틸화 효소 억제제로서의 헤테로시클릭알킬 유도체 화합물 및 이를 포함하는 약제학적 조성물 | |
| CN104302640A (zh) | 3,5-二氨基吡唑激酶抑制剂 | |
| EP1587788B1 (en) | 2,7-substituted indoles and their use as 5-ht6 modulators | |
| JP6434528B2 (ja) | 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用 | |
| RU2006105777A (ru) | Индол-6-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6 | |
| JP2006519812A (ja) | フェニルスルホン誘導体およびｃｎｓ障害の治療におけるその使用 | |
| JP2007500168A5 (OSRAM) | ||
| CN102892754A (zh) | 芳基磺酰胺ccr3拮抗剂 | |
| US20100197668A1 (en) | 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | |
| EP1412028B1 (en) | Tetrahydroindolone derivatives linked to arylpiperazines | |
| ES2313319T3 (es) | 3-((hetero)arilsulfonil)-8-((aminoalkil)oxi)quinolinas como antagonistas del receptor 5-ht6 para el tratamiento del snc. | |
| ES2244243T3 (es) | Deerivados de quinazolinona. | |
| RU2006105778A (ru) | Индол-4-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6 |